We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Hesham Abboud

Hesham Abboud MD, PhD

Assistant Professor of Neurology, Case Western Reserve University School of Medicine; Director, Multiple Sclerosis and Neuroimmunology Program; Staff Neurologist, Parkinson’s and Movement Disorders Center, University Hospitals, Cleveland Medical Center, Cleveland, Ohio

Hesham Abboud, MD, PhD, is the Director of the Multiple Sclerosis and Neuroimmunology Program at University Hospitals and a staff neurologist at the Parkinson's and Movement Disorders Center. He is an Assistant Professor of Neurology at Case Western Reserve University School of Medicine. His special interests include Multiple Sclerosis, neuromyelitis optica, autoimmune encephalitis, autoimmune movement disorders, spinal movement disorders, spasticity management, and neuromodulation.

Dr. Abboud earned his medical degree from Alexandria University in Egypt, where he also completed an internship and a residency in Neurology and Psychiatry. He obtained his Masters and Doctorate degrees in Neurology from Alexandria University before joining the Cleveland Clinic where he completed a residency in adult neurology, a clinical fellowship in movement disorders and neuromodulation, and a clinical fellowship in multiple sclerosis and neuroimmunology. Dr. Abboud received special training in neuromyelitis optica and autoimmune neurology at Johns Hopkins University.

Disclosures

Dr. Abboud is a consultant and speaker for Biogen, Genentech, Bristol-Myer-Squibb, Alexion, and Viela-Bio. He receives research support to conduct clinical trials for Genentech, Bristol-Myer-Squibb, Novartis, and Sanofi-Genzyme.